What does NGNE company do? | Glauxie AI

Q: What does NGNE company do?

Neurogene Inc. (NGNE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Rachel L. McMinn. Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy... Employees: 131.

Q: Who is the CEO of NGNE?

Find out who leads NGNE — CEO name, executive team, and compensation details.

Q: What sector is NGNE in?

Find NGNE sector, industry, and sub-industry classification with sector peer comparison.

Q: What are NGNE competitors?

Compare NGNE to its top competitors with side-by-side financials, valuation, and performance.

What does NGNE company do?

🦉

Neurogene Inc. (NGNE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEORachel L. McMinn

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5...

Key Executives

Name	Title
Andrew E. Mulberg FAAP	Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control
Arvind Sreedharan	Senior Vice President of Business Operations
Christina Shafer	Chief Commercial Officer
Christine Mikail Cvijic	President, CFO & Director
Donna Cochener-Metcalfe	Senior Vice President, General Counsel & Corporate Secretary
Julie Jordan	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

NGNE Profile Financials

Who is the CEO of NGNE? What sector is NGNE in? What are NGNE competitors?